WO2021243885A1 - Gate-control radiography injection device and injection method - Google Patents

Gate-control radiography injection device and injection method Download PDF

Info

Publication number
WO2021243885A1
WO2021243885A1 PCT/CN2020/116108 CN2020116108W WO2021243885A1 WO 2021243885 A1 WO2021243885 A1 WO 2021243885A1 CN 2020116108 W CN2020116108 W CN 2020116108W WO 2021243885 A1 WO2021243885 A1 WO 2021243885A1
Authority
WO
WIPO (PCT)
Prior art keywords
module
pressure
acquisition module
invasive
injection
Prior art date
Application number
PCT/CN2020/116108
Other languages
French (fr)
Chinese (zh)
Inventor
刘广志
Original Assignee
苏州润迈德医疗科技有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 苏州润迈德医疗科技有限公司 filed Critical 苏州润迈德医疗科技有限公司
Publication of WO2021243885A1 publication Critical patent/WO2021243885A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/007Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests for contrast media
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/021Measuring pressure in heart or blood vessels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/021Measuring pressure in heart or blood vessels
    • A61B5/0215Measuring pressure in heart or blood vessels by means inserted into the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/20Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/31Details
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/20Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
    • A61M2005/2006Having specific accessories
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/33Controlling, regulating or measuring
    • A61M2205/3331Pressure; Flow
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00Measuring parameters of the user
    • A61M2230/04Heartbeat characteristics, e.g. ECG, blood pressure modulation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00Measuring parameters of the user
    • A61M2230/08Other bio-electrical signals

Definitions

  • the invention relates to the technical field of coronary artery medicine, in particular to a gated contrast injection device and an injection method.
  • Angiography is a commonly used and effective method for diagnosing vascular lesions. It is a relatively safe and reliable invasive diagnostic technique. It has been widely used in clinical practice and is regarded as the "gold standard" for diagnosing vascular stenosis.
  • the angiographic images can obtain morphological parameters such as vessel diameter, stenosis, length, blood flow, etc., and can also measure electrocardiogram and aortic pressure during surgery, and measure functional indicators (such as blood flow reserve fractions) through more advanced computational fluid dynamics (FFR) can indicate the influence of coronary artery stenosis on the distal blood flow, and the diagnosis of myocardial ischemia has become a recognized indicator for the functional evaluation of vascular stenosis).
  • FFR advanced computational fluid dynamics
  • a series of diagnosis depends on the blood vessel development displayed by the contrast image, and the quality of the contrast image directly affects the diagnosis effect. Whether the doctor visually inspects the degree of vascular stenosis or makes QCA measurement and caFFR measurement through auxiliary software, high-quality contrast images are required as the basis.
  • Contrast surgery is to insert the second tube through the femoral artery or radial artery, and send it to the target blood vessel, and inject the contrast agent to visualize the blood vessel.
  • the method for injecting the contrast agent includes manually pushing the syringe or pushing the contrast agent in the syringe by a motor and a mechanical structure through a high-pressure syringe to inject the contrast agent into the blood vessel through the second pipeline.
  • the contrast agent bolus is not concentrated due to the amount of force exerted by the surgeon and the speed of the pushing speed, the contrast agent is not filled, the quality of the contrast image is poor, and the blood flow rate obtained through the flow of the contrast agent also fluctuates.
  • the high-pressure injector can ensure the rapid and stable injection of the contrast agent into the blood vessel by setting a fixed injection speed and pressure, which can improve the quality of the contrast image.
  • the coronary blood supply is mainly in the diastolic phase.
  • the blood flow is slow or even stopped due to the compression of the coronary blood vessels by the myocardium, causing the contrast agent to overflow into the aorta. Since the time of the bolus contrast agent is uncertain at the stage of the heartbeat cycle, it cannot guarantee that the contrast agent enters the coronary artery smoothly, which affects the method of calculating the flow rate based on the flow of the contrast agent, such as the TIMI frame counting method.
  • the present application provides a gated contrast injection device and injection method to solve the problem that the manual bolus injection in the prior art has poor control of the force and the pushing speed, and the uncertainty of the bolus time in both high-pressure syringes and manual boluses. It cannot be guaranteed that the contrast agent enters the coronary artery smoothly, which affects the problem of poor accuracy in calculating the flow rate based on the flow of the contrast agent.
  • the present application provides a gated contrast injection device, comprising: a control module, a pressure acquisition module and a drive module respectively connected to the control module, and a drive module connected to the drive module Injection module
  • the pressure acquisition module is used to measure the invasive pressure of the aorta or/and the ECG signal in real time;
  • the control module is configured to receive the invasive pressure or/and the ECG signal sent by the pressure acquisition module in real time, control whether the drive module starts working according to the pressure signal and the ECG signal, and control the The working power of the drive module;
  • the driving module is used to start or stop work according to the instructions sent by the control module, and to set the working power;
  • the injection module is used to generate a corresponding thrust with the rotation of the driving module, thereby controlling the injection rate of the liquid.
  • the pressure acquisition module is an invasive pressure acquisition module for real-time measurement of the invasive pressure of the aorta.
  • the pressure acquisition module is an ECG acquisition module for real-time measurement of the ECG signal of the aorta, including non-invasive pressure.
  • the pressure acquisition module includes: an invasive pressure acquisition module and an ECG acquisition module, and the invasive pressure acquisition module is used to measure the invasive pressure of the aorta in real time;
  • the ECG acquisition module is used to measure the ECG signal of the aorta in real time, including non-invasive pressure.
  • the aforementioned gated contrast injection device further includes: a three-way valve, the first branch of the three-way valve is connected to the invasive pressure acquisition module through a first pipeline, and is used for real-time measurement of the The invasive pressure of the aorta; the second branch of the three-way valve is connected to the injection module through a second pipeline, and is used to make the liquid in the second pipeline uniformly driven by the injection module Move; the third branch of the three-way valve is connected to an external contrast catheter through a third pipeline.
  • the ECG acquisition module is a data transmission module, connected to an external electrocardiograph, and used to transmit the ECG signal collected by the electrocardiograph to the Control module.
  • control module is a central processing unit.
  • the driving module is a driving motor, or/and the injection module is a liquid injector.
  • the invasive pressure acquisition module includes: a housing, an integrated circuit board, a blood pressure sensor, a PIN connector, a first connection structure and a through tube; the blood pressure sensor, an integrated The circuit board and the PIN connector are both arranged in the housing; the blood pressure sensor is communicatively connected with the integrated circuit board through the PIN connector;
  • the through pipe is arranged on the top of the housing, a through hole is provided on the inner surface of the through pipe, and one end of the through pipe is connected to the first pipeline;
  • One end of the blood pressure sensor is a pressure collecting end, and the pressure collecting end is sealed in the through hole for collecting the pressure value of the liquid flowing through the through tube;
  • the first connection structure is respectively connected with the housing, the integrated circuit board, and the control module, and is used to transmit the pressure value collected by the blood pressure sensor to the control module.
  • the PIN connector includes: a body, and a signal transmission mechanism and a grasping mechanism provided on the body; one end of the signal transmission mechanism is connected to the blood pressure sensor , The other end is connected with the integrated circuit, and the grasping mechanism is detachably mounted on the body.
  • this application provides an injection method of a gated contrast injection device, including:
  • the method of controlling whether the drive module is turned on according to the pressure signal or/and the ECG signal includes:
  • the first image interval and the second image interval are compared, and the start time of the overlap of the first image interval and the second image interval is determined as the time when the driving module is activated.
  • This application provides a gated contrast injection device that collects the invasive pressure waveform or/and electrocardiogram of the aorta through a pressure acquisition module, and the control module controls the opening or closing of the driving module according to the received pressure waveform or/and the electrocardiogram, and drives The module drives the injection module to move, thereby ensuring that the contrast agent is injected synchronously at the beginning of the diastole, so that the contrast agent and blood flow quickly enter the coronary blood vessels during the diastole, and control the working power of the drive module when it is turned on, the working power and the bolus Corresponding to the pressure, the bolus injection pressure affects the injection rate of the injection module, which can effectively control the stability of the injection efficiency and improve the quality of the contrast.
  • Figure 1 is a structural block diagram of an embodiment of a gated contrast injection device
  • Fig. 2 is a structural block diagram of another embodiment of a gated contrast injection device
  • Figure 3 is a perspective view of the invasive pressure acquisition module
  • Fig. 4 is a schematic structural view of Fig. 3 with the lower casing hidden;
  • Figure 5 is a perspective view of the invasive pressure acquisition module with the upper shell hidden
  • Figure 6 is a schematic diagram of the exploded structure of the PIN connector
  • Figure 7 is a schematic diagram of the structure of the upper shell and the through pipe
  • Fig. 8 is a flowchart of the gated contrast injection method of the present application.
  • Control module 100 pressure acquisition module 200, invasive pressure acquisition module 210, housing 211, integrated circuit board 212, blood pressure sensor 213, pressure acquisition terminal 2131, PIN connector 214, body 2141, signal transmission mechanism 2142, grasping mechanism 2143, first connection structure 215, through pipe 216, through hole 217, ECG acquisition module 220, drive module 300, injection module 400, three-way valve 500, first branch 510, second branch 520, third branch 530, The first pipeline 600, the second pipeline 700, and the third pipeline 800.
  • the present application provides a gated contrast injection device, including: a control module 100, a pressure acquisition module 200 and a drive module 300 respectively connected to the control module 100, and a control module connected to the drive module 300 Injection module 400; pressure acquisition module 200, used to measure the invasive pressure or/and ECG signal of the aorta in real time; control module 100 used to receive the invasive pressure or/and ECG signal sent by the pressure acquisition module 200 in real time, according to The pressure signal and the ECG signal control whether the driving module 300 starts to work and the working power of the driving module 300; the driving module 300 is used to start or stop working and set the working power according to the instructions sent by the control module 100; the injection module 400 It is used to generate corresponding thrust with the rotation of the driving module 300, thereby controlling the injection rate of the liquid.
  • the diastolic pressure waveform or/and the ECG diastolic interval are set in the control module 100 in advance, and then the pressure acquisition module 200 collects the invasive pressure waveform or/and the electrocardiogram of the aorta, and the control module 100 according to the received pressure waveform Or/and the electrocardiogram control the opening or closing of the driving module 300, the driving module 300 drives the injection module 400 to move, thereby ensuring that the contrast agent is injected synchronously at the beginning of the diastole, so that the contrast agent and blood flow quickly enter the coronary artery during the diastole
  • the blood vessel controls the working power of the driving module 300 when it is opened.
  • the working power corresponds to the bolus pressure.
  • the bolus pressure affects the injection rate of the injection module 400, which can effectively control the stability of the injection efficiency and improve the quality of the imaging.
  • the calculation of FFR, iFR, dPR and IMR, CFR and other functional parameters based on angiography provides reliable flow measurement, which solves the problem of manual bolus injection in the prior art.
  • the bolus time is uncertain, which cannot guarantee that the contrast agent enters the coronary artery smoothly, which affects the problem of poor accuracy in calculating the flow rate based on the flow of the contrast agent.
  • the pressure acquisition module 200 is an invasive pressure acquisition module 210, which is used to measure the invasive pressure of the aorta in real time. Since the pressure of the heart changes in real time, the invasive pressure is The test is more real-time, so the invasive pressure test is more accurate than the non-invasive pressure test.
  • the invasive pressure collection module 210 is a disposable blood pressure collection device, which can avoid blood infection between patients and is safer and more reliable to use.
  • the pressure acquisition module 200 is an ECG acquisition module 220, which is used to measure the ECG signal of the aorta in real time, including non-invasive pressure.
  • the ECG acquisition module 220 is a data transmission module, connected to an external electrocardiograph, and used to transmit the ECG signal collected by the electrocardiograph to the control module 100.
  • the patient is subjected to an electrocardiogram examination by the electrocardiogram installed in the catheterization room, and then the examination result is transmitted to the control module 100 through the electrocardiogram acquisition module 220, which has a simple structure and low cost.
  • the pressure acquisition module 200 includes: an invasive pressure acquisition module 210 and an ECG acquisition module 220.
  • the invasive pressure acquisition module 210 is used to measure the invasive pressure of the aorta in real time;
  • the ECG acquisition module 220 is used to measure the ECG signal of the aorta in real time, including non-invasive pressure.
  • the preferred method of the present application is to have both the invasive pressure acquisition module 210 and the ECG acquisition module 220. With this configuration, the pressure formed by the invasive pressure acquisition module 210 can be combined with the ECG waveform of the ECG acquisition module 220. By comparison, it is concluded that the time is at the beginning of the diastole, and the time of the bolus injection is more accurate and the error is reduced.
  • an embodiment of the present application further includes: a three-way valve 500.
  • the first branch 510 of the three-way valve 500 is connected to the invasive pressure acquisition module 210 through the first pipeline 600 for real-time measurement.
  • the invasive pressure of the aorta; the second branch 520 of the three-way valve 500 is connected to the injection module 400 through the second pipeline 700, and is used to make the liquid in the second pipeline 700 move uniformly under the push of the injection module 400 ;
  • the third branch 530 of the three-way valve 500 is connected to the external contrast catheter through the third pipeline 800.
  • the bolus injection pressure matching the bolus injection rate and the working efficiency of the driving module 300 are set in the control module 100 in advance.
  • the bolus injection pressure is controlled by the working efficiency, and the bolus injection pressure determines the bolus injection rate, thereby ensuring that the bolus injection is more stable. Improve the quality of imaging.
  • control module 100 is a central processing unit.
  • the driving module 300 is a driving motor, such as a servo motor;
  • the injection module 400 is a liquid injector.
  • the invasive pressure acquisition module 210 includes: a housing 211, an integrated circuit board 212, a blood pressure sensor 213, a PIN connector 214, and a A connecting structure 215 and a through tube 216; the blood pressure sensor 213, the integrated circuit board 212, and the PIN connector 214 are all arranged in the housing 211; the blood pressure sensor 213 is communicatively connected with the integrated circuit board 212 through the PIN connector 214; away from the first connection In the direction of structure 215, the through pipe 216 is set on the top of the housing 211, the through hole 217 is provided on the inner surface of the through pipe 216, and one end of the through pipe 216 is connected to the first pipeline 600; one end of the blood pressure sensor 213 is the pressure collection end 2131, The end 2131 is sealed in the through hole 217 as shown in FIG.
  • the first connection structure 215 is connected to the housing 211, the integrated circuit board 212, and the control module 100, respectively , Used to transmit the pressure value collected by the blood pressure sensor 213 to the control module 100.
  • the housing 211, the blood pressure sensor 213, the PIN connector 214, and the first connection structure 215 are arranged as a whole, which not only realizes the collection and transmission of the blood pressure sensor 213, but also improves the tightness of the blood pressure sensor 213. All are integrated in In the housing 211, the volume is reduced, and the first connection structure 215 is connected with external equipment, which realizes a detachable arrangement and is convenient to assemble.
  • the first connection structure 215 realizes the transmission of the pressure value. Since the liquid only flows in the sealed structure composed of the through pipe 216, the through hole 217 and the pressure collecting end 2131, it will not contact other structures, which improves the service life of each component and is scrapped. The rate is low, maintenance and production costs are reduced, and it has the advantages of simple structure and simple procedures.
  • the PIN connector 214 includes a body 2141, and a signal transmission mechanism 2142 and a grasping mechanism 2143 provided on the body 2141; one end of the signal transmission mechanism 2142 is connected to the blood pressure sensor 213 , The other end is connected to the integrated circuit board 212, and the grasping mechanism 2143 is detachably mounted on the body 2141. Since the length, width, and height of the PIN connector body 2141 are all less than 1cm, the body 2141 has a small volume, which makes it difficult to grasp and install. Because of the small size of the body 2141, it is necessary to grab the body 2141 and prevent it from being grasped.
  • the present application is provided with a detachable grasping mechanism 2143 on the main body 2141. If the PIN connector needs to be installed on the invasive pressure acquisition module 210, The grasping mechanism 2143 is installed on the body 2141, and the grasping mechanism 2143 is accurately grasped and installed on the invasive blood pressure collection device manually or through a mechanical structure; if the installation is completed, the grasping mechanism 2143 is manually or through a mechanical structure.
  • this application provides a gated contrast injection method, including:
  • controlling whether the drive module is turned on and the working power when turned on according to the pressure signal or/and the ECG signal including:

Abstract

A gate-control radiography injection device and an injection method. The device comprises: a control module (100); a pressure acquisition module (200) and a drive module (300) which are respectively connected to the control module (100); and an injection module (400) connected to the drive module (300). The pressure acquisition module (200) is used for measuring an invasive pressure signal or/and an electrocardiosignal of an aorta in real time. The control module (100) is used for receiving the invasive pressure signal or/and the electrocardiosignal in real time, and controlling, according to the pressure signal and the electrocardiosignal, the drive module (300) to operate and the operating power of the drive module (300). The drive module (300) is used for starting to operate or stopping operating according to an instruction and setting the operating power. The injection module (400) is used for generating a corresponding thrust force along with rotation of the drive module (300), and then controlling the injection rate of liquid. According to the present application, a contrast medium can be injected synchronously in the beginning of diastole, so that the contrast medium and blood flow can rapidly enter a coronary vessel during the diastole; and by controlling the operating power of the drive module (300), the stability of injection efficiency can be effectively controlled, and the quality of radiography can be improved.

Description

一种门控造影注射装置及注射方法Gated contrast injection device and injection method 技术领域Technical field
本发明涉及冠状动脉医学技术领域,特别是涉及一种门控造影注射装置及注射方法。The invention relates to the technical field of coronary artery medicine, in particular to a gated contrast injection device and an injection method.
背景技术Background technique
血管造影是诊断血管病变的一种常用而且有效的方法,是一种较为安全可靠的有创诊断技术,现已广泛应用于临床,被认为是诊断血管狭窄病变的“金标准”。Angiography is a commonly used and effective method for diagnosing vascular lesions. It is a relatively safe and reliable invasive diagnostic technique. It has been widely used in clinical practice and is regarded as the "gold standard" for diagnosing vascular stenosis.
通过造影图像可以获取血管管径、狭窄度、长度、血流等形态学参数,还可以在手术中测量心电图和主动脉压,通过更先进的计算流体力学测量功能性指标(如血流储备分数(FFR)可表明冠脉狭窄病变对远端血流产生的影响,诊断心肌是否缺血,已经成为血管狭窄功能性评价的公认指标)。一系列的诊断都依赖于造影图像显示的血管显影,造影图像的质量直接影响诊断的效果。无论医生以目测血管狭窄程度还是通过辅助软件做QCA测量、caFFR测量都需要有高质量的造影图像作为基础。The angiographic images can obtain morphological parameters such as vessel diameter, stenosis, length, blood flow, etc., and can also measure electrocardiogram and aortic pressure during surgery, and measure functional indicators (such as blood flow reserve fractions) through more advanced computational fluid dynamics (FFR) can indicate the influence of coronary artery stenosis on the distal blood flow, and the diagnosis of myocardial ischemia has become a recognized indicator for the functional evaluation of vascular stenosis). A series of diagnosis depends on the blood vessel development displayed by the contrast image, and the quality of the contrast image directly affects the diagnosis effect. Whether the doctor visually inspects the degree of vascular stenosis or makes QCA measurement and caFFR measurement through auxiliary software, high-quality contrast images are required as the basis.
造影手术是将第二管路经股动脉或桡动脉插入,送至目标血管,注入造影剂,使血管显影。其中造影剂的注射方法包括手工推动注射器或通过高压注射器由电机及机械结构推动注射器内的造影剂经由第二管路推注到血管内。手工推注因为不同术者用力大小及推动速度的快慢导致造影剂推注不集中,造影剂不充盈,造影图像质量差,通过造影剂流动获取血流速度也有所波动。高压注射器可以通过设置固定的推注速度及压力保证造影剂快速稳定的推注到血管内,可以提高造影图像质量。然而由于心脏不断跳动,冠脉供血主要在心脏舒张期,在心脏收缩期由于心肌挤压冠脉血管导致血流前进缓慢甚至停止,造成 造影剂溢出到主动脉。由于推注造影剂的时间不确定处于心跳周期的那个阶段,也无法保证造影剂顺利进入冠脉,进而影响根据造影剂流动计算流速的方法,如TIMI计帧法等。Contrast surgery is to insert the second tube through the femoral artery or radial artery, and send it to the target blood vessel, and inject the contrast agent to visualize the blood vessel. The method for injecting the contrast agent includes manually pushing the syringe or pushing the contrast agent in the syringe by a motor and a mechanical structure through a high-pressure syringe to inject the contrast agent into the blood vessel through the second pipeline. In manual bolus injection, the contrast agent bolus is not concentrated due to the amount of force exerted by the surgeon and the speed of the pushing speed, the contrast agent is not filled, the quality of the contrast image is poor, and the blood flow rate obtained through the flow of the contrast agent also fluctuates. The high-pressure injector can ensure the rapid and stable injection of the contrast agent into the blood vessel by setting a fixed injection speed and pressure, which can improve the quality of the contrast image. However, due to the continuous beating of the heart, the coronary blood supply is mainly in the diastolic phase. During the systole, the blood flow is slow or even stopped due to the compression of the coronary blood vessels by the myocardium, causing the contrast agent to overflow into the aorta. Since the time of the bolus contrast agent is uncertain at the stage of the heartbeat cycle, it cannot guarantee that the contrast agent enters the coronary artery smoothly, which affects the method of calculating the flow rate based on the flow of the contrast agent, such as the TIMI frame counting method.
发明内容Summary of the invention
本申请提供了一种门控造影注射装置及注射方法,以解决现有技术中手工推注存在的用力大小和推动速度不好控制,以及高压注射器和手动推注均存在推注时间不确定,无法保证造影剂顺利进入冠脉,进而影响根据造影剂流动计算流速准确性差的问题。The present application provides a gated contrast injection device and injection method to solve the problem that the manual bolus injection in the prior art has poor control of the force and the pushing speed, and the uncertainty of the bolus time in both high-pressure syringes and manual boluses. It cannot be guaranteed that the contrast agent enters the coronary artery smoothly, which affects the problem of poor accuracy in calculating the flow rate based on the flow of the contrast agent.
为实现上述目的,第一方面,本申请提供了一种门控造影注射装置,包括:控制模块,以及分别与所述控制模块连接的压力采集模块和驱动模块,以及与所述驱动模块连接的注射模块;In order to achieve the foregoing objective, in the first aspect, the present application provides a gated contrast injection device, comprising: a control module, a pressure acquisition module and a drive module respectively connected to the control module, and a drive module connected to the drive module Injection module
所述压力采集模块,用于实时测量主动脉的有创压力或/和心电信号;The pressure acquisition module is used to measure the invasive pressure of the aorta or/and the ECG signal in real time;
所述控制模块,用于实时接收所述压力采集模块发送的有创压力或/和心电信号,根据所述压力信号和所述心电信号控制所述驱动模块是否开始工作,以及控制所述驱动模块的工作功率;The control module is configured to receive the invasive pressure or/and the ECG signal sent by the pressure acquisition module in real time, control whether the drive module starts working according to the pressure signal and the ECG signal, and control the The working power of the drive module;
所述驱动模块,用于根据所述控制模块发送的指令开始或者停止工作,以及设置工作功率;The driving module is used to start or stop work according to the instructions sent by the control module, and to set the working power;
所述注射模块,用于随着所述驱动模块的转动而产生相应的推力,进而控制液体的注射速率。The injection module is used to generate a corresponding thrust with the rotation of the driving module, thereby controlling the injection rate of the liquid.
可选地,上述的门控造影注射装置中,所述压力采集模块为有创压力采集模块,用于实时测量主动脉的有创压力。Optionally, in the gated contrast injection device described above, the pressure acquisition module is an invasive pressure acquisition module for real-time measurement of the invasive pressure of the aorta.
可选地,上述的门控造影注射装置中,所述压力采集模块为心电采集模块,用于实时测量主动脉的心电信号,包括无创压力。Optionally, in the gated contrast injection device described above, the pressure acquisition module is an ECG acquisition module for real-time measurement of the ECG signal of the aorta, including non-invasive pressure.
可选地,上述的门控造影注射装置中,所述压力采集模块包括:有创压力 采集模块和心电采集模块,所述有创压力采集模块用于实时测量主动脉的有创压力;所述心电采集模块用于实时测量主动脉的心电信号,包括无创压力。Optionally, in the gated contrast injection device described above, the pressure acquisition module includes: an invasive pressure acquisition module and an ECG acquisition module, and the invasive pressure acquisition module is used to measure the invasive pressure of the aorta in real time; The ECG acquisition module is used to measure the ECG signal of the aorta in real time, including non-invasive pressure.
可选地,上述的门控造影注射装置中,还包括:三通阀,所述三通阀的第一分支通过第一管路与所述有创压力采集模块连接,用于实时测量所述主动脉的有创压力;所述三通阀的第二分支通过第二管路与所述注射模块连接,用于使所述第二管路内的液体在所述注射模块的推动下匀速的移动;所述三通阀的第三分支通过第三管路与外部的造影导管连接。Optionally, the aforementioned gated contrast injection device further includes: a three-way valve, the first branch of the three-way valve is connected to the invasive pressure acquisition module through a first pipeline, and is used for real-time measurement of the The invasive pressure of the aorta; the second branch of the three-way valve is connected to the injection module through a second pipeline, and is used to make the liquid in the second pipeline uniformly driven by the injection module Move; the third branch of the three-way valve is connected to an external contrast catheter through a third pipeline.
可选地,上述的门控造影注射装置中,所述心电采集模块为数据传输模块,与外部的心电仪连接,用于将所述心电仪采集到的心电信号传递给所述控制模块。Optionally, in the gated contrast injection device described above, the ECG acquisition module is a data transmission module, connected to an external electrocardiograph, and used to transmit the ECG signal collected by the electrocardiograph to the Control module.
可选地,上述的门控造影注射装置中,所述控制模块为中央处理器。Optionally, in the gated contrast injection device described above, the control module is a central processing unit.
可选地,上述的门控造影注射装置中,所述驱动模块为驱动电机,或/和所述注射模块为液体注射器。Optionally, in the gated contrast injection device described above, the driving module is a driving motor, or/and the injection module is a liquid injector.
可选地,上述的门控造影注射装置中,所述有创压力采集模块包括:壳体、集成电路板、血压传感器、PIN连接器、第一连接结构和通管;所述血压传感器、集成电路板、PIN连接器均设置于所述壳体内;所述血压传感器通过所述PIN连接器与所述集成电路板通讯连接;Optionally, in the gated contrast injection device described above, the invasive pressure acquisition module includes: a housing, an integrated circuit board, a blood pressure sensor, a PIN connector, a first connection structure and a through tube; the blood pressure sensor, an integrated The circuit board and the PIN connector are both arranged in the housing; the blood pressure sensor is communicatively connected with the integrated circuit board through the PIN connector;
远离所述第一连接结构方向,所述通管设置于所述壳体顶部,所述通管内表面上设置通孔,所述通管一端与所述第一管路连接;Away from the direction of the first connection structure, the through pipe is arranged on the top of the housing, a through hole is provided on the inner surface of the through pipe, and one end of the through pipe is connected to the first pipeline;
所述血压传感器的一端为压力采集端,所述压力采集端密封于所述通孔内,用于采集从所述通管内流过液体的压力值;One end of the blood pressure sensor is a pressure collecting end, and the pressure collecting end is sealed in the through hole for collecting the pressure value of the liquid flowing through the through tube;
所述第一连接结构分别与所述壳体、所述集成电路板、所述控制模块连接,用于向所述控制模块传输所述血压传感器采集的压力值。The first connection structure is respectively connected with the housing, the integrated circuit board, and the control module, and is used to transmit the pressure value collected by the blood pressure sensor to the control module.
可选地,上述的门控造影注射装置中,所述PIN连接器包括:本体,以及 设置于所述本体上的信号传输机构和抓取机构;所述信号传输机构一端与所述血压传感器连接,另一端与所述集成电路连接,所述抓取机构可拆卸地安装于所述本体上。Optionally, in the gated contrast injection device described above, the PIN connector includes: a body, and a signal transmission mechanism and a grasping mechanism provided on the body; one end of the signal transmission mechanism is connected to the blood pressure sensor , The other end is connected with the integrated circuit, and the grasping mechanism is detachably mounted on the body.
第二方面,本申请提供了一种门控造影注射装置的注射方法,包括:In the second aspect, this application provides an injection method of a gated contrast injection device, including:
实时测量主动脉的有创压力或/和心电信号;Real-time measurement of the invasive pressure or/and ECG signal of the aorta;
根据所述压力信号或/和所述心电信号控制驱动模块是否开启以及开启时的工作功率;According to the pressure signal or/and the ECG signal, control whether the driving module is turned on and the working power when it is turned on;
随着所述驱动模块的转动而产生相应的推力,进而控制液体的注射速率。With the rotation of the driving module, a corresponding thrust is generated, thereby controlling the injection rate of the liquid.
可选地,上述的门控造影装置的注射方法中,所述根据所述压力信号或/和所述心电信号控制驱动模块是否开启的方法,包括:Optionally, in the injection method of the gated contrast device described above, the method of controlling whether the drive module is turned on according to the pressure signal or/and the ECG signal includes:
查找所述有创压力信号产生的压力波形属于舒张期的图像区间,即第一图像区间;Searching for an image interval in which the pressure waveform generated by the invasive pressure signal belongs to the diastolic period, that is, the first image interval;
查找所述心电信号产生的心电图处于舒张期的图像区间,即第二图像区间;Searching for an image interval in which the electrocardiogram generated by the electrocardiogram signal is in the diastolic phase, that is, the second image interval;
比较所述第一图像区间与所述第二图像区间,判断得出所述第一图像区间与所述第二图像区间重叠的开始时间作为启动所述驱动模块的时刻。The first image interval and the second image interval are compared, and the start time of the overlap of the first image interval and the second image interval is determined as the time when the driving module is activated.
本申请实施例提供的方案带来的有益效果至少包括:The beneficial effects brought about by the solutions provided by the embodiments of the present application include at least:
本申请提供了一种门控造影注射装置,通过压力采集模块采集主动脉的有创压力波形或/和心电图,控制模块根据接收到的压力波形或/和心电图控制驱动模块的开启或者关闭,驱动模块带动注射模块移动,进而保证在心脏舒张期开始时同步推注造影剂,使造影剂和血流在心脏舒张期快速进入冠脉血管,开启时控制驱动模块的工作功率,工作功率与推注压力相对应,推注压力影响注射模块的注射速率,能够有效的控制注射效率的稳定性,提高了造影质量,为进一步进行基于造影的FFR、iFR、dPR和IMR、CFR等功能学参数的计算提 供可靠的流速测量,解决了现有技术中手工推注存在的用力大小和推动速度不好控制,以及高压注射器和手动推注均存在推注时间不确定,无法保证造影剂顺利进入冠脉,进而影响根据造影剂流动计算流速准确性差的问题。This application provides a gated contrast injection device that collects the invasive pressure waveform or/and electrocardiogram of the aorta through a pressure acquisition module, and the control module controls the opening or closing of the driving module according to the received pressure waveform or/and the electrocardiogram, and drives The module drives the injection module to move, thereby ensuring that the contrast agent is injected synchronously at the beginning of the diastole, so that the contrast agent and blood flow quickly enter the coronary blood vessels during the diastole, and control the working power of the drive module when it is turned on, the working power and the bolus Corresponding to the pressure, the bolus injection pressure affects the injection rate of the injection module, which can effectively control the stability of the injection efficiency and improve the quality of the contrast. In order to further calculate the FFR, iFR, dPR and IMR, CFR and other functional parameters based on the contrast Provide reliable flow rate measurement, solve the problem of manual bolus injection in the prior art, which is difficult to control the force and pushing speed, and the bolus time is uncertain in both high-pressure syringes and manual boluses, which cannot guarantee the smooth entry of the contrast agent into the coronary artery. This further affects the problem of poor accuracy in calculating the flow rate based on the contrast agent flow.
附图说明Description of the drawings
此处所说明的附图用来提供对本发明的进一步理解,构成本发明的一部分,本发明的示意性实施例及其说明用于解释本发明,并不构成对本发明的不当限定。在附图中:The drawings described here are used to provide a further understanding of the present invention and constitute a part of the present invention. The exemplary embodiments of the present invention and the description thereof are used to explain the present invention, and do not constitute an improper limitation of the present invention. In the attached picture:
图1为门控造影注射装置的一个实施例的结构框图;Figure 1 is a structural block diagram of an embodiment of a gated contrast injection device;
图2为门控造影注射装置的另一实施例的结构框图;Fig. 2 is a structural block diagram of another embodiment of a gated contrast injection device;
图3为有创压力采集模块的立体图;Figure 3 is a perspective view of the invasive pressure acquisition module;
图4为隐藏下壳体的图3的结构示意图;Fig. 4 is a schematic structural view of Fig. 3 with the lower casing hidden;
图5为隐藏上壳体的有创压力采集模块的立体图;Figure 5 is a perspective view of the invasive pressure acquisition module with the upper shell hidden;
图6为PIN连接器的爆炸结构示意图;Figure 6 is a schematic diagram of the exploded structure of the PIN connector;
图7为上壳体和通管的结构示意图;Figure 7 is a schematic diagram of the structure of the upper shell and the through pipe;
图8为本申请的门控造影注射方法的流程图;Fig. 8 is a flowchart of the gated contrast injection method of the present application;
下面对附图标记进行说明:The reference signs are described below:
控制模块100,压力采集模块200,有创压力采集模块210,壳体211,集成电路板212,血压传感器213,压力采集端2131,PIN连接器214,本体2141,信号传输机构2142,抓取机构2143,第一连接结构215,通管216,通孔217,心电采集模块220,驱动模块300,注射模块400,三通阀500,第一分支510,第二分支520,第三分支530,第一管路600,第二管路700,第三管路800。 Control module 100, pressure acquisition module 200, invasive pressure acquisition module 210, housing 211, integrated circuit board 212, blood pressure sensor 213, pressure acquisition terminal 2131, PIN connector 214, body 2141, signal transmission mechanism 2142, grasping mechanism 2143, first connection structure 215, through pipe 216, through hole 217, ECG acquisition module 220, drive module 300, injection module 400, three-way valve 500, first branch 510, second branch 520, third branch 530, The first pipeline 600, the second pipeline 700, and the third pipeline 800.
具体实施方式detailed description
为使本发明的目的、技术方案和优点更加清楚,下面将结合本发明具体实施例及相应的附图对本发明技术方案进行清楚、完整地描述。显然,所描述的实施例仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施 例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。In order to make the objectives, technical solutions, and advantages of the present invention clearer, the technical solutions of the present invention will be clearly and completely described below in conjunction with specific embodiments of the present invention and the corresponding drawings. Obviously, the described embodiments are only a part of the embodiments of the present invention, rather than all the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by those of ordinary skill in the art without creative work shall fall within the protection scope of the present invention.
以下将以图式揭露本发明的多个实施方式,为明确说明起见,许多实务上的细节将在以下叙述中一并说明。然而,应了解到,这些实务上的细节不应用以限制本发明。也就是说,在本发明的部分实施方式中,这些实务上的细节是非必要的。此外,为简化图式起见,一些习知惯用的结构与组件在图式中将以简单的示意的方式绘示之。Several embodiments of the present invention will be disclosed in the following drawings. For clear description, many practical details will be described in the following description. However, it should be understood that these practical details should not be used to limit the present invention. That is to say, in some embodiments of the present invention, these practical details are unnecessary. In addition, for the sake of simplification of the drawings, some conventionally used structures and components will be shown in simple schematic ways in the drawings.
如图1所示,本申请提供了一种门控造影注射装置,包括:控制模块100,以及分别与控制模块100连接的压力采集模块200和驱动模块300,以及与所述驱动模块300连接的注射模块400;压力采集模块200,用于实时测量主动脉的有创压力或/和心电信号;控制模块100用于实时接收压力采集模块200发送的有创压力或/和心电信号,根据压力信号和心电信号控制驱动模块300是否开始工作,以及控制驱动模块300的工作功率;驱动模块300用于根据控制模块100发送的指令开始或者停止工作,以及设置工作功率;所述注射模块400用于随着驱动模块300的转动而产生相应的推力,进而控制液体的注射速率。本申请通过预先在控制模块100内设置舒张期压力波形或/和心电图舒张期区间,再通过压力采集模块200采集主动脉的有创压力波形或/和心电图,控制模块100根据接收到的压力波形或/和心电图控制驱动模块300的开启或者关闭,驱动模块300带动注射模块400移动,进而保证在心脏舒张期开始时同步推注造影剂,使造影剂和血流在心脏舒张期快速进入冠脉血管,开启时控制驱动模块300的工作功率,工作功率与推注压力相对应,推注压力影响注射模块400的注射速率,能够有效的控制注射效率的稳定性,提高了造影质量,为进一步进行基于造影的FFR、iFR、dPR和IMR、CFR等功能学参数的计算提供可靠的流速测量,解决了现有技术中手工推注存在的用力大小和推动速度不好控制,以及高压注射器和手动推注均存在推注时间不确定,无法保证造影剂顺利进入冠脉,进而影响根据造影剂流动计算流速准确性差的问题。As shown in Figure 1, the present application provides a gated contrast injection device, including: a control module 100, a pressure acquisition module 200 and a drive module 300 respectively connected to the control module 100, and a control module connected to the drive module 300 Injection module 400; pressure acquisition module 200, used to measure the invasive pressure or/and ECG signal of the aorta in real time; control module 100 used to receive the invasive pressure or/and ECG signal sent by the pressure acquisition module 200 in real time, according to The pressure signal and the ECG signal control whether the driving module 300 starts to work and the working power of the driving module 300; the driving module 300 is used to start or stop working and set the working power according to the instructions sent by the control module 100; the injection module 400 It is used to generate corresponding thrust with the rotation of the driving module 300, thereby controlling the injection rate of the liquid. In this application, the diastolic pressure waveform or/and the ECG diastolic interval are set in the control module 100 in advance, and then the pressure acquisition module 200 collects the invasive pressure waveform or/and the electrocardiogram of the aorta, and the control module 100 according to the received pressure waveform Or/and the electrocardiogram control the opening or closing of the driving module 300, the driving module 300 drives the injection module 400 to move, thereby ensuring that the contrast agent is injected synchronously at the beginning of the diastole, so that the contrast agent and blood flow quickly enter the coronary artery during the diastole The blood vessel controls the working power of the driving module 300 when it is opened. The working power corresponds to the bolus pressure. The bolus pressure affects the injection rate of the injection module 400, which can effectively control the stability of the injection efficiency and improve the quality of the imaging. The calculation of FFR, iFR, dPR and IMR, CFR and other functional parameters based on angiography provides reliable flow measurement, which solves the problem of manual bolus injection in the prior art. In all injections, the bolus time is uncertain, which cannot guarantee that the contrast agent enters the coronary artery smoothly, which affects the problem of poor accuracy in calculating the flow rate based on the flow of the contrast agent.
如图2所示,本申请的一个实施例中,压力采集模块200为有创压力采集模块210,用于实时测量主动脉的有创压力,由于心脏的压力是实时变化的,有创压力的测试实时性更强,因此有创压力相较于无创压力的测试更加准确。有创压力采集模块210为一次性血压采集装置,能够避免病人之间血液的感染,使用更加安全可靠。As shown in FIG. 2, in an embodiment of the present application, the pressure acquisition module 200 is an invasive pressure acquisition module 210, which is used to measure the invasive pressure of the aorta in real time. Since the pressure of the heart changes in real time, the invasive pressure is The test is more real-time, so the invasive pressure test is more accurate than the non-invasive pressure test. The invasive pressure collection module 210 is a disposable blood pressure collection device, which can avoid blood infection between patients and is safer and more reliable to use.
如图2所示,本申请的一个实施例中,压力采集模块200为心电采集模块220,用于实时测量主动脉的心电信号,包括无创压力。优选地,心电采集模块220为数据传输模块,与外部的心电仪连接,用于将心电仪采集到的心电信号传递给控制模块100。如此设置,通过设置于导管室的心电仪对患者进行心电图检查,然后将检查结果通过心电采集模块220传递给控制模块100,结构简单,成本低。As shown in FIG. 2, in an embodiment of the present application, the pressure acquisition module 200 is an ECG acquisition module 220, which is used to measure the ECG signal of the aorta in real time, including non-invasive pressure. Preferably, the ECG acquisition module 220 is a data transmission module, connected to an external electrocardiograph, and used to transmit the ECG signal collected by the electrocardiograph to the control module 100. With this arrangement, the patient is subjected to an electrocardiogram examination by the electrocardiogram installed in the catheterization room, and then the examination result is transmitted to the control module 100 through the electrocardiogram acquisition module 220, which has a simple structure and low cost.
如图2所示,本申请的一个实施例中,压力采集模块200包括:有创压力采集模块210和心电采集模块220,有创压力采集模块210用于实时测量主动脉的有创压力;心电采集模块220用于实时测量主动脉的心电信号,包括无创压力。本申请的优选方式是同时具有有创压力采集模块210和心电采集模块220,如此设置,可以将有创压力采集模块210采集到的压力形成的波形与心电采集模块220的心电波形进行比较,得出时间均处于舒张期的开始时刻,推注的时刻更加精确,减小误差。As shown in FIG. 2, in an embodiment of the present application, the pressure acquisition module 200 includes: an invasive pressure acquisition module 210 and an ECG acquisition module 220. The invasive pressure acquisition module 210 is used to measure the invasive pressure of the aorta in real time; The ECG acquisition module 220 is used to measure the ECG signal of the aorta in real time, including non-invasive pressure. The preferred method of the present application is to have both the invasive pressure acquisition module 210 and the ECG acquisition module 220. With this configuration, the pressure formed by the invasive pressure acquisition module 210 can be combined with the ECG waveform of the ECG acquisition module 220. By comparison, it is concluded that the time is at the beginning of the diastole, and the time of the bolus injection is more accurate and the error is reduced.
如图2所示,本申请的一个实施例中,还包括:三通阀500,三通阀500的第一分支510通过第一管路600与有创压力采集模块210连接,用于实时测量主动脉的有创压力;三通阀500的第二分支520通过第二管路700与与注射模块400连接,用于使第二管路700内的液体在注射模块400的推动下匀速的移动;三通阀500的第三分支530通过第三管路800与外部的造影导管连接。本申请预先在控制模块100内设置与推注速率相匹配的推注压力和驱动模块300的工作效率,通过工作效率控制推注压力,推注压力决定推注速率,进而 保证推注更加平稳,提高造影质量。As shown in FIG. 2, an embodiment of the present application further includes: a three-way valve 500. The first branch 510 of the three-way valve 500 is connected to the invasive pressure acquisition module 210 through the first pipeline 600 for real-time measurement. The invasive pressure of the aorta; the second branch 520 of the three-way valve 500 is connected to the injection module 400 through the second pipeline 700, and is used to make the liquid in the second pipeline 700 move uniformly under the push of the injection module 400 ; The third branch 530 of the three-way valve 500 is connected to the external contrast catheter through the third pipeline 800. In this application, the bolus injection pressure matching the bolus injection rate and the working efficiency of the driving module 300 are set in the control module 100 in advance. The bolus injection pressure is controlled by the working efficiency, and the bolus injection pressure determines the bolus injection rate, thereby ensuring that the bolus injection is more stable. Improve the quality of imaging.
本申请的一个实施例中,控制模块100为中央处理器。驱动模块300为驱动电机,例如:伺服电机;注射模块400为液体注射器。In an embodiment of the present application, the control module 100 is a central processing unit. The driving module 300 is a driving motor, such as a servo motor; the injection module 400 is a liquid injector.
如图3、图4、图5和图6所示,本申请的一个实施例中,有创压力采集模块210包括:壳体211、集成电路板212、血压传感器213、PIN连接器214、第一连接结构215和通管216;血压传感器213、集成电路板212、PIN连接器214均设置于壳体211内;血压传感器213通过PIN连接器214与集成电路板212通讯连接;远离第一连接结构215方向,通管216设置于壳体211顶部,通管216内表面上设置通孔217,通管216一端与第一管路600连接;血压传感器213的一端为压力采集端2131,压力采集端2131密封于如图7所示的通孔217内,用于采集从通管216内流过液体的压力值;第一连接结构215分别与壳体211、集成电路板212、控制模块100连接,用于向控制模块100传输血压传感器213采集的压力值。本申请将壳体211、血压传感器213、PIN连接器214和第一连接结构215设置成一个整体,既实现了血压传感器213端的采集和传输,又提高了血压传感器213的密封性,全部集成于壳体211内,减小了体积,通过第一连接结构215与外部设备连接,实现了可拆卸设置,组装方便。由于血压传感器213的压力采集端2131密封于通孔217内,通孔217与通管216连通,能够实时采集液体压力,不与外部环境接触,提高了测量的准确性;通过PIN连接器214、第一连接结构215实现压力值的传输,由于液体只在通管216、通孔217和压力采集端2131组成的密封结构内流动,不会接触到其他结构,提高了各部件的使用寿命,报废率低,降了维修和生产成本,且具有结构简单、工序简单的优点。As shown in Figures 3, 4, 5 and 6, in an embodiment of the present application, the invasive pressure acquisition module 210 includes: a housing 211, an integrated circuit board 212, a blood pressure sensor 213, a PIN connector 214, and a A connecting structure 215 and a through tube 216; the blood pressure sensor 213, the integrated circuit board 212, and the PIN connector 214 are all arranged in the housing 211; the blood pressure sensor 213 is communicatively connected with the integrated circuit board 212 through the PIN connector 214; away from the first connection In the direction of structure 215, the through pipe 216 is set on the top of the housing 211, the through hole 217 is provided on the inner surface of the through pipe 216, and one end of the through pipe 216 is connected to the first pipeline 600; one end of the blood pressure sensor 213 is the pressure collection end 2131, The end 2131 is sealed in the through hole 217 as shown in FIG. 7 for collecting the pressure value of the liquid flowing through the through pipe 216; the first connection structure 215 is connected to the housing 211, the integrated circuit board 212, and the control module 100, respectively , Used to transmit the pressure value collected by the blood pressure sensor 213 to the control module 100. In this application, the housing 211, the blood pressure sensor 213, the PIN connector 214, and the first connection structure 215 are arranged as a whole, which not only realizes the collection and transmission of the blood pressure sensor 213, but also improves the tightness of the blood pressure sensor 213. All are integrated in In the housing 211, the volume is reduced, and the first connection structure 215 is connected with external equipment, which realizes a detachable arrangement and is convenient to assemble. Since the pressure collection end 2131 of the blood pressure sensor 213 is sealed in the through hole 217, the through hole 217 is connected to the through pipe 216, and the liquid pressure can be collected in real time without contact with the external environment, which improves the accuracy of the measurement; through the PIN connector 214, The first connection structure 215 realizes the transmission of the pressure value. Since the liquid only flows in the sealed structure composed of the through pipe 216, the through hole 217 and the pressure collecting end 2131, it will not contact other structures, which improves the service life of each component and is scrapped. The rate is low, maintenance and production costs are reduced, and it has the advantages of simple structure and simple procedures.
如图7所示,本申请的一个实施例中,PIN连接器214包括:本体2141,以及设置于本体2141上的信号传输机构2142和抓取机构2143;信号传输机构2142一端与血压传感器213连接,另一端与集成电路板212连接,抓取机 构2143可拆卸地安装于本体2141上。由于PIN连接器的本体2141长、宽、高的尺寸均小于1cm,因此本体2141体积很小,抓取安装存在难度;由于本体2141体积小,又要抓取到本体2141,又要防止抓取力度过大损伤本体2141,因此在不损坏本体2141的情况下精确抓取本体2141存在难度。为了解决在不损坏本体2141的情况下快速精准抓取的问题,本申请在本体2141上设置可拆卸的抓取机构2143,如果需要将PIN连接器安装于有创压力采集模块210上时,则将抓取机构2143安装于本体2141上,人为或者通过机械结构将抓取机构2143精准的抓起、安装于有创血压采集装置上;如果安装完成,则人为或者通过机械结构将抓取机构2143从本体2141上取下,减小抓取机构2143在本体2141上的占用体积,降低PIN连接器的体积,进而节约有创压力采集模块210的内部空间,便于提高有创压力采集模块210的集成度。As shown in FIG. 7, in an embodiment of the present application, the PIN connector 214 includes a body 2141, and a signal transmission mechanism 2142 and a grasping mechanism 2143 provided on the body 2141; one end of the signal transmission mechanism 2142 is connected to the blood pressure sensor 213 , The other end is connected to the integrated circuit board 212, and the grasping mechanism 2143 is detachably mounted on the body 2141. Since the length, width, and height of the PIN connector body 2141 are all less than 1cm, the body 2141 has a small volume, which makes it difficult to grasp and install. Because of the small size of the body 2141, it is necessary to grab the body 2141 and prevent it from being grasped. Excessive force damages the main body 2141, so it is difficult to accurately grasp the main body 2141 without damaging the main body 2141. In order to solve the problem of fast and accurate grasping without damaging the main body 2141, the present application is provided with a detachable grasping mechanism 2143 on the main body 2141. If the PIN connector needs to be installed on the invasive pressure acquisition module 210, The grasping mechanism 2143 is installed on the body 2141, and the grasping mechanism 2143 is accurately grasped and installed on the invasive blood pressure collection device manually or through a mechanical structure; if the installation is completed, the grasping mechanism 2143 is manually or through a mechanical structure. Remove from the main body 2141, reduce the occupied volume of the grasping mechanism 2143 on the main body 2141, reduce the volume of the PIN connector, thereby saving the internal space of the invasive pressure acquisition module 210, and facilitate the improvement of the integration of the invasive pressure acquisition module 210 Spend.
如图8所示,本申请提供了门控造影注射方法,包括:As shown in Figure 8, this application provides a gated contrast injection method, including:
S100,实时测量主动脉的有创压力或/和心电信号;S100, real-time measurement of the invasive pressure or/and ECG signal of the aorta;
S200,根据所述压力信号或/和所述心电信号控制驱动模块是否开启以及开启时的工作功率,包括:S200, controlling whether the drive module is turned on and the working power when turned on according to the pressure signal or/and the ECG signal, including:
查找所述有创压力信号产生的压力波形属于舒张期的图像区间,即第一图像区间;Searching for an image interval in which the pressure waveform generated by the invasive pressure signal belongs to the diastolic period, that is, the first image interval;
查找所述心电信号产生的心电图处于舒张期的图像区间,即第二图像区间;Searching for an image interval in which the electrocardiogram generated by the electrocardiogram signal is in the diastolic phase, that is, the second image interval;
比较所述第一图像区间与所述第二图像区间,判断得出所述第一图像区间与所述第二图像区间重叠的开始时间作为启动所述驱动模块的时刻;Comparing the first image interval with the second image interval, and judging that the start time when the first image interval overlaps with the second image interval is determined as the time when the driving module is started;
S300,随着所述驱动模块的转动而产生相应的推力,进而控制液体的注射速率。S300, with the rotation of the driving module, a corresponding thrust is generated, thereby controlling the injection rate of the liquid.
本发明的以上所述的具体实例,对本发明的目的、技术方案和有益效果进 行了进一步详细说明,所应理解的是,以上所述仅为本发明的具体实施例而已,并不用于限制本发明,凡在本发明的精神和原则之内,所做的任何修改、等同替换、改进等,均应包含在本发明的保护范围之内。The above-mentioned specific examples of the present invention further describe the purpose, technical solutions and beneficial effects of the present invention in detail. It should be understood that the above are only specific embodiments of the present invention and are not intended to limit the present invention. The invention, any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present invention shall be included in the protection scope of the present invention.

Claims (12)

  1. 一种门控造影注射装置,其特征在于,包括:控制模块,以及分别与所述控制模块连接的压力采集模块和驱动模块,以及与所述驱动模块连接的注射模块;A gated contrast injection device, characterized by comprising: a control module, a pressure acquisition module and a driving module respectively connected to the control module, and an injection module connected to the driving module;
    所述压力采集模块,用于实时测量主动脉的有创压力或/和心电信号;The pressure acquisition module is used to measure the invasive pressure of the aorta or/and the ECG signal in real time;
    所述控制模块,用于实时接收所述压力采集模块发送的有创压力或/和心电信号,根据所述压力信号和所述心电信号控制所述驱动模块是否开始工作,以及控制所述驱动模块的工作功率;The control module is configured to receive the invasive pressure or/and the ECG signal sent by the pressure acquisition module in real time, control whether the drive module starts working according to the pressure signal and the ECG signal, and control the The working power of the drive module;
    所述驱动模块,用于根据所述控制模块发送的指令开始或者停止工作,设置工作功率;The driving module is used to start or stop work according to the instruction sent by the control module, and set the working power;
    所述注射模块,用于随着所述驱动模块的转动而产生相应的推力,进而控制液体的注射速率。The injection module is used to generate a corresponding thrust with the rotation of the driving module, thereby controlling the injection rate of the liquid.
  2. 根据权利要求1所述的门控造影注射装置,其特征在于,所述压力采集模块为有创压力采集模块,用于实时测量主动脉的有创压力。The gated contrast injection device according to claim 1, wherein the pressure acquisition module is an invasive pressure acquisition module for real-time measurement of the invasive pressure of the aorta.
  3. 根据权利要求1所述的门控造影注射装置,其特征在于,所述压力采集模块为心电采集模块,用于实时测量主动脉的心电信号,包括无创压力。The gated contrast injection device according to claim 1, wherein the pressure acquisition module is an ECG acquisition module for real-time measurement of the ECG signal of the aorta, including non-invasive pressure.
  4. 根据权利要求1所述的门控造影注射装置,其特征在于,所述压力采集模块包括:有创压力采集模块和心电采集模块,所述有创压力采集模块用于实时测量主动脉的有创压力;所述心电采集模块用于实时测量主动脉的心电信号,包括无创压力。The gated contrast injection device according to claim 1, wherein the pressure acquisition module comprises: an invasive pressure acquisition module and an ECG acquisition module, and the invasive pressure acquisition module is used for real-time measurement of the aortic pressure Invasive pressure; the ECG acquisition module is used to measure the ECG signal of the aorta in real time, including non-invasive pressure.
  5. 根据权利要求2或4所述的门控造影注射装置,其特征在于,还包括:三通阀,所述三通阀的第一分支通过第一管路与所述有创压力采集模块连接,用于实时测量所述主动脉的有创压力;所述三通阀的第二分支通过第二管路与所述注射模块连接,用于使所述第二管路内的液体在所述注射模块的推动下匀 速的移动;所述三通阀的第三分支通过第三管路与外部的造影导管连接。The gated contrast injection device according to claim 2 or 4, further comprising: a three-way valve, the first branch of the three-way valve is connected to the invasive pressure acquisition module through a first pipeline, It is used to measure the invasive pressure of the aorta in real time; the second branch of the three-way valve is connected to the injection module through a second pipeline, and is used to make the liquid in the second pipeline be injected into the The module moves at a uniform speed under the push of the module; the third branch of the three-way valve is connected to the external contrast catheter through the third pipeline.
  6. 根据权利要求3或4所述的门控造影注射装置,其特征在于,所述心电采集模块为数据传输模块,与外部的心电仪连接,用于将所述心电仪采集到的心电信号传递给所述控制模块。The gated contrast injection device according to claim 3 or 4, wherein the ECG acquisition module is a data transmission module, which is connected to an external electrocardiograph, and is used to collect the heartbeat collected by the electrocardiograph. The electrical signal is transmitted to the control module.
  7. 根据权利要求1所述的门控造影注射装置,其特征在于,所述控制模块为中央处理器。The gated contrast injection device according to claim 1, wherein the control module is a central processing unit.
  8. 根据权利要求1所述的门控造影注射装置,其特征在于,所述驱动模块为驱动电机,或/和所述注射模块为液体注射器。The gated contrast injection device according to claim 1, wherein the driving module is a driving motor, or/and the injection module is a liquid injector.
  9. 根据权利要求5所述的门控造影注射装置,其特征在于,所述有创压力采集模块包括:壳体、集成电路板、血压传感器、PIN连接器、第一连接结构和通管;所述血压传感器、集成电路板、PIN连接器均设置于所述壳体内;所述血压传感器通过所述PIN连接器与所述集成电路板通讯连接;The gated contrast injection device according to claim 5, wherein the invasive pressure acquisition module comprises: a housing, an integrated circuit board, a blood pressure sensor, a PIN connector, a first connection structure and a through pipe; The blood pressure sensor, the integrated circuit board, and the PIN connector are all arranged in the housing; the blood pressure sensor is communicatively connected with the integrated circuit board through the PIN connector;
    远离所述第一连接结构方向,所述通管设置于所述壳体顶部,所述通管内表面上设置通孔,所述通管一端与所述第一管路连接;Away from the direction of the first connection structure, the through pipe is arranged on the top of the housing, a through hole is provided on the inner surface of the through pipe, and one end of the through pipe is connected to the first pipeline;
    所述血压传感器的一端为压力采集端,所述压力采集端密封于所述通孔内,用于采集从所述通管内流过液体的压力值;One end of the blood pressure sensor is a pressure collecting end, and the pressure collecting end is sealed in the through hole for collecting the pressure value of the liquid flowing through the through tube;
    所述第一连接结构分别与所述壳体、所述集成电路板、所述控制模块连接,用于向所述控制模块传输所述血压传感器采集的压力值。The first connection structure is respectively connected with the housing, the integrated circuit board, and the control module, and is used to transmit the pressure value collected by the blood pressure sensor to the control module.
  10. 根据权利要求9所述的门控造影注射装置,其特征在于,所述PIN连接器包括:本体,以及设置于所述本体上的信号传输机构和抓取机构;所述信号传输机构一端与所述血压传感器连接,另一端与所述集成电路连接,所述抓取机构可拆卸地安装于所述本体上。The gated contrast injection device according to claim 9, wherein the PIN connector comprises a body, and a signal transmission mechanism and a grasping mechanism provided on the body; one end of the signal transmission mechanism is connected to the The blood pressure sensor is connected, the other end is connected with the integrated circuit, and the grabbing mechanism is detachably mounted on the body.
  11. 权利要求1~10任一项所述的门控造影注射装置的注射方法,其特征在于,包括:The injection method of the gated contrast injection device according to any one of claims 1 to 10, characterized in that it comprises:
    实时测量主动脉的有创压力或/和心电信号;Real-time measurement of the invasive pressure or/and ECG signal of the aorta;
    根据所述压力信号或/和所述心电信号控制驱动模块是否开启以及开启时的工作功率;According to the pressure signal or/and the ECG signal, control whether the driving module is turned on and the working power when it is turned on;
    随着所述驱动模块的转动而产生相应的推力,进而控制液体的注射速率。With the rotation of the driving module, a corresponding thrust is generated, thereby controlling the injection rate of the liquid.
  12. 根据权利要求11所述的门控造影装置的注射方法,其特征在于,所述根据所述压力信号或/和所述心电信号控制驱动模块是否开启的方法,包括:The injection method of a gated radiography device according to claim 11, wherein the method of controlling whether the drive module is turned on according to the pressure signal or/and the ECG signal comprises:
    查找所述有创压力信号产生的压力波形属于舒张期的图像区间,即第一图像区间;Searching for an image interval in which the pressure waveform generated by the invasive pressure signal belongs to the diastolic period, that is, the first image interval;
    查找所述心电信号产生的心电图处于舒张期的图像区间,即第二图像区间;Searching for an image interval in which the electrocardiogram generated by the electrocardiogram signal is in the diastolic phase, that is, the second image interval;
    比较所述第一图像区间与所述第二图像区间,判断得出所述第一图像区间与所述第二图像区间重叠的开始时间作为启动所述驱动模块的时刻。The first image interval and the second image interval are compared, and the start time of the overlap of the first image interval and the second image interval is determined as the time when the driving module is activated.
PCT/CN2020/116108 2020-06-04 2020-09-18 Gate-control radiography injection device and injection method WO2021243885A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN202010500806.2 2020-06-04
CN202010500806.2A CN112138247A (en) 2020-06-04 2020-06-04 Gate-controlled radiography injection device and injection method

Publications (1)

Publication Number Publication Date
WO2021243885A1 true WO2021243885A1 (en) 2021-12-09

Family

ID=73891854

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2020/116108 WO2021243885A1 (en) 2020-06-04 2020-09-18 Gate-control radiography injection device and injection method

Country Status (2)

Country Link
CN (1) CN112138247A (en)
WO (1) WO2021243885A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115518227A (en) * 2022-11-23 2022-12-27 吉林省安特麦迪科技有限公司 Full-automatic contrast injection device and method
CN117085201A (en) * 2023-09-07 2023-11-21 北京唯迈医疗设备有限公司 Image recognition-based contrast agent injection automatic control method and system
CN117085201B (en) * 2023-09-07 2024-04-19 北京唯迈医疗设备有限公司 Image recognition-based contrast agent injection automatic control method and system

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101330872A (en) * 2005-12-15 2008-12-24 皇家飞利浦电子股份有限公司 A method for determining a degree of pulsatility in angiography
CN103596500A (en) * 2011-03-11 2014-02-19 拜斯特医药有限公司 Universal measuring module for medical application and method for assembling the measuring module
US20140249485A1 (en) * 2000-10-18 2014-09-04 Bayer Medical Care, Inc. Injector System With A Manual Control Device
CN105126237A (en) * 2015-06-26 2015-12-09 中国人民解放军总医院 Double-mode heart in-situ perfusion system
CN108815642A (en) * 2018-04-22 2018-11-16 王连生 A kind of opacifying injection system
CN110151167A (en) * 2019-05-20 2019-08-23 苏州润迈德医疗科技有限公司 A kind of collector and method that can measure electrocardio and invasive blood pressure simultaneously
CN212547849U (en) * 2020-06-04 2021-02-19 苏州润迈德医疗科技有限公司 Door-controlled radiography injection device

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140249485A1 (en) * 2000-10-18 2014-09-04 Bayer Medical Care, Inc. Injector System With A Manual Control Device
CN101330872A (en) * 2005-12-15 2008-12-24 皇家飞利浦电子股份有限公司 A method for determining a degree of pulsatility in angiography
CN103596500A (en) * 2011-03-11 2014-02-19 拜斯特医药有限公司 Universal measuring module for medical application and method for assembling the measuring module
CN105126237A (en) * 2015-06-26 2015-12-09 中国人民解放军总医院 Double-mode heart in-situ perfusion system
CN108815642A (en) * 2018-04-22 2018-11-16 王连生 A kind of opacifying injection system
CN110151167A (en) * 2019-05-20 2019-08-23 苏州润迈德医疗科技有限公司 A kind of collector and method that can measure electrocardio and invasive blood pressure simultaneously
CN212547849U (en) * 2020-06-04 2021-02-19 苏州润迈德医疗科技有限公司 Door-controlled radiography injection device

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115518227A (en) * 2022-11-23 2022-12-27 吉林省安特麦迪科技有限公司 Full-automatic contrast injection device and method
CN117085201A (en) * 2023-09-07 2023-11-21 北京唯迈医疗设备有限公司 Image recognition-based contrast agent injection automatic control method and system
CN117085201B (en) * 2023-09-07 2024-04-19 北京唯迈医疗设备有限公司 Image recognition-based contrast agent injection automatic control method and system

Also Published As

Publication number Publication date
CN112138247A (en) 2020-12-29

Similar Documents

Publication Publication Date Title
US20230157557A1 (en) Determination of cardiac parameters for modulation of blood pump support
CN212234408U (en) System for measuring the performance of a beating heart
US5014715A (en) Device for measuring the impedance to flow of a natural or prosthetic vessel in a living body
JP3534419B2 (en) Blood flow circulating assist device using continuous flow blood pump and diagnostic device for blood flow circulating state of living body
WO2020199309A1 (en) Novel invasive blood pressure sensor
JPWO2018227156A5 (en) Determination of cardiac parameters to modulate blood pump support
US20100094113A1 (en) Hemodynamic monitoring during automated measurement of blood constituents
WO2021243885A1 (en) Gate-control radiography injection device and injection method
CN111081126A (en) Blood vessel intervention operation simulator
JPH04166130A (en) Heart function measuring apparatus
CN212547849U (en) Door-controlled radiography injection device
CN204765607U (en) Multipurpose invasive pressure monitoring sensing device
CN111840757B (en) Pressure measurable sacculus pipe and intelligent self-evolution auxiliary equipment thereof
CN108815642A (en) A kind of opacifying injection system
CN209018705U (en) A kind of sealing device for OCT conduit
CN215426146U (en) Novel three-way connecting plate for cardiovascular coronary angiography and pressure measurement
Karimov et al. The axial continuous-flow blood pump: Bench evaluation of changes in flow associated with changes of inflow cannula angle
JP2004073875A (en) Blood flow circulation auxiliary device using continuous flow blood pump, and diagnostic apparatus for examining blood flow circulation state of living body
WO2020181645A1 (en) Invasive blood pressure detection apparatus and detection system
CN213993545U (en) Pressurizing device for venous pressure detection
CN212756824U (en) Disposable heart catheter panoramic endoscopic and drug administration device
CN215128535U (en) Disposable invasive blood pressure sensor
CN201691912U (en) Device for detecting myocardial fractional flow reserve through micro catheter
CN111588974A (en) Disposable heart catheter panoramic endoscopic and drug administration device
CN117462101A (en) Nondestructive testing device for electronic sphygmomanometer

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 20939221

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 20939221

Country of ref document: EP

Kind code of ref document: A1

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 07.07.2023)

122 Ep: pct application non-entry in european phase

Ref document number: 20939221

Country of ref document: EP

Kind code of ref document: A1